NCT05117242 2026-04-30Safety and Efficacy Study of GEN1046 as a Single Agent or in Combination With Pembrolizumab for Treatment of Recurrent (Non-small Cell) Lung CancerGenmabPhase 2 Active not recruiting125 enrolled